Abstract
The gamut of neoplastic and pseudoneoplastic conditions that may seed the pleural surface is extensive and can be divided into primary and metastatic neoplasm. In addition, the pleura may be the site for tumors of different lineage including epithelial, mesenchymal, neural, and neuroectodermal, as well as lymphoid neoplasms. However, in order to properly assess the origin of lesions seeding the pleural surface, it is important to properly correlate findings with imaging studies, which can be of important aid in addressing issues such as extent of disease and possible origin. In this chapter, the emphasis will be in primary pleural lesions leaving the issue of metastatic disease in the context of differential diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Own observations. Unreported data.
References
Hinds MW. Mesothelioma in the United States: incidence in the 1970s. J Occup Med. 1978;20:469–71.
National Cancer Institute. SEER Cancer Statistics Review 1975–2003. http://seer.cancer.gov/csr/1975_2003/results_merged/sect_17mesothelioma.pdf. Accessed 3 Jan 2012.
Craighead JE. The epidemiology and pathogenesis of malignant mesothelioma. Chest. 1989;96:92–3.
Wright WE, Sherwin RP. Histological types of malignant mesothelioma and asbestos exposure. Br J Ind Med. 1984;41:514–7.
Borow M, Conston A, Livornese L, et al. Mesothelioma following exposure to asbestos: a review of 72 cases. Chest. 1973;64:641–6.
Wagner E. Das tuberkelähnliche Lymphadenom. Arch F Heilk. 1870;11:497–525.
Robertson HE. Endothelioma of the pleura. J Cancer Res. 1923–1924;8:317.
Klemperer P, Rabin CB. Primary neoplasms of the pleura. Arch Pathol. 1931;11:385–412.
DuBray ES, Rosson FB. Primary mesothelioma of the pleura: a clinical and pathological contribution to the pleural malignancy, with report of a case. Arch Intern Med. 1920;26:715–37.
Godwin MC. Diffuse mesotheliomas: with comment on their relation to localized fibrous mesotheliomas. Cancer. 1957;10:298–319.
Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Town province. Br J Ind Med. 1960;17:260–71.
Hirsch A, Brochard P, Cremoux H, et al. Features of asbestos-exposed and unexposed mesothelioma. Am J Ind Med. 1982;3:413–22.
McCaughey WTE. Criteria for the diagnosis of diffuse mesothelial tumors. Ann N Y Acad Sci. 1965;132:603–13.
Huncharek M, Kelsey K, Mark EJ, et al. Treatment and survival in diffuse malignant pleural mesothelioma: a study of 83 cases from Massachusetts General Hospital. Anticancer Res. 1996;16:1265–8.
Aaisner J, Wiernik PH. Malignant mesothelioma: current status and future prospects. Chest. 1978;74:438–44.
Gardner MJ, Acheson ED, Winter PD. Mortality from mesothelioma of the pleura during 1968–78 in England and Wales. Br J Cancer. 1982;46:81–8.
Oels HC, Harrison EG, Carr DT, Bernatz PE. Diffuse malignant mesothelioma of the pleura: a review of 37 cases. Chest. 1971;60:564–70.
Chahinian AP, Pajak TF, Holland JF, et al. Diffuse malignant mesothelioma: prospective evaluation of 69 patients. Ann Intern Med. 1982;96:746–55.
Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura: review of 123 patients. Cancer. 1982;49:2431–5.
Law MR, Hodson ME, Heard BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behavior. Thorax. 1982;37:810–5.
Qua JC, Rao UMN, Takita H. Malignant pleural mesothelioma: a clinicopathological study. J Surg Oncol. 1993;54:47–50.
Suzuki Y. Pathology of human malignant mesothelioma. Semin Oncol. 1980;8:268–82.
Grundy GW, Miller RW. Malignant mesothelioma in childhood: report of 13 cases. Cancer. 1972;30:1216–8.
Moran CA, Suster S, Albores-Saavedra J. Peritoneal mesotheliomas in children: a clinicopathologic study of 8 cases. Histopathology. 2008;52:824–30.
Peterson JT, Greenberg DS, Buffler PA. Non-asbestos related malignant mesothelioma. A review. Cancer. 1984;54:951–60.
Crotty TB, Myers JL, Katzenstein AL, et al. Localized malignant mesothelioma. A clinicopathologic and flow cytometric study. Am J Surg Pathol. 1994;18:357–63.
Ordoñez NG. Epithelial mesothelioma with deciduoid features: report of four cases. Am J Surg Pathol. 2000;24:816–23.
Ordoñez NG, Mackay B. Clear cell mesothelioma. Ultrastruct Pathol. 1996;20:331–6.
Henderson DW, Attwood HD, Constance TJ, Shilkin KB, Steele RH. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol. 1988;12:367–84.
Yousem SA, Hochholzer L. Malignant mesothelioma with osseous and cartilaginous differentiation. Arch Pathol Lab Med. 1987;111:62–6.
Weissferdt A, Kalhor N, Suster S. Malignant mesothelioma with prominent adenomatoid features: a clinicopathological and immunohistochemical study of 10 cases. Ann Diagn Pathol. 2011;15:25–9.
Arrossi AV, Lin E, Rice D, Moran CA. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. Am J Clin Pathol. 2008;130:754–64.
Moran CA, Wick MR, Suster S. The role of immunohistochemistry in the diagnosis of malignant mesothelioma. Semin Diagn Pathol. 2000;17:178–83.
Suster S, Moran CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol. 2006;13:316–29.
Wick MR, Moran CA, Mills SE, Suster S. Immunohistochemical differential diagnosis of pleural effusions with emphasis on malignant mesothelioma. Curr Opin Pulm Med. 2001;7:187–92.
Ordonez NG. Valued of cytokeratin 5/6 immunostain in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215–21.
Ordonez NG. In search for a positive immunohistochemical marker for mesothelioma: an update. Adv Anat Pathol. 1998;5:53–60.
Moll R, Dhouailly D, Sun TT. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas: an immunohistochemical study using monoclonal antibody AE14. Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;58:129–45.
Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6: a potential marker for epithelioid mesothelioma. Histopathology. 1997;31:140–3.
Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol. 2002;15:6–10.
Gotzos V, Vogt P, Celio MR. The calcium binding protein calretinin is a selective marker for malignant mesothelial proliferation using formalin-fixed paraffin sections. J Pathol. 1992;192:137–47.
Dogliioni C, dei Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol. 1996;20:1037–46.
Dei Tos AP, Doglioni C. Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol. 1998;5:61–6.
Oates J, Edwards C. HBME-1, MOC31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology. 2000;36:341–7.
Foster MR, Johnson JE, Olson SJ, et al. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesothelioma and primary pulmonary adenocarcinoma. Arch Pathol Lab Med. 2001;125:1316–20.
Kuman-Sing S, Segers K, Rodeck U, et al. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell type transition and prognosis. J Pathol. 1997;181:67–74.
Yazjii H, Battifora H, Barry TS, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol. 2006;19:514–23.
Amin KM, Litzky LA, Smythe RW, et al. Wilm’s tumor −1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol. 1995;146:344–56.
Walker C, Rutten F, Yuan X, et al. Wilms’ tumor suppressor gene expression in rat and human mesothelioma. Cancer Res. 1994;54:3101–6.
Ordonez NG. The value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol. 2000;24:598–606.
Miettinen M, Kovatich AJ. HMBE-1 – a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft tissue and bone tumors. Appl Immunohistochem. 1995;3:115–22.
Kennedy AD, King G, Kerr KM. HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of the pleura. J Clin Pathol. 1997;50:859–62.
Attanoos RL, Goddard H, Gibbs AR. Mesothelioma-binding antibodies: thrombomodulin, OV632, and HBME-1 and their use for the diagnosis of malignant mesothelioma. Histopathology. 1996;29:209–15.
Collins CL, Ordonez SG, Schaefer R, et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol. 1992;141:827–33.
Ascoli V, Scalso CC, Taccogna S, et al. the diagnostic value of thrombomodulin immunolocalization in serous effusions. Arch Pathol Lab Med. 1995;119:1136–40.
Argani P, Iacobuziio-Donahue C, Ryu B, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression. Clin Cancer Res. 2001;7:3862–8.
Ordonez NG. Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol. 2003;27:1418–28.
Hassan R, Kreitman RJ, Pastan I, et al. Localization of mesothelin in epithelial ovarian cancer. Appl Immunohistochem Mol Morphol. 2005;13:243–7.
Cao D, Ji H, Ronnett BM. Expression of mesothelin, fascin, prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. Int J Gynecol Pathol. 2005;24:67–72.
Comin CE, Novelli L, Boddi V, et al. Calretinin, thrombomodulin, CEA, and CD-15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma. Hum Pathol. 2001;32:529–36.
Garcia-Prats MD, Ballestin C, Sotelo T, et al. A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumors. Histopathology. 1998;32:462–72.
Roberts F, Harper CM, Downie I, et al. Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma: a study of thirteen antibodies. Am J Clin Pathol. 2001;116:253–62.
Leosli H, Hurliman J. Immunohistochemical study of malignant diffuse mesothelioma of the pleura. Histopathology. 1984;8:793–803.
Battifora H, Kopinsky M. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer. 1985;55:1679–85.
Pfaltz M, Odermatt B, Christen B, et al. Immunohistochemistry in the diagnosis of malignant mesothelioma. Virchows Arch. 1987;411:387–93.
Otis CN, Carter D, Cole S, et al. Immunnohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. Am J Surg Pathol. 1987;11:445–56.
Wharhol MJ. The ultrastructural localization of keratin proteins and carcinoembryonic antigen in malignant mesothelioma. Am J Pathol. 1984;116:385–90.
Sosolik RC, McGauhy VR, De Young BR. Anti-MOC31: a potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel. Mod Pathol. 1997;10:716–9.
Ordonez NG. The value of MOC31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. Hum Pathol. 1998;29:166–9.
Gonzalez-Lois C, Ballentin C, Sotelo M, et al. Combined use of novel epithelial (MOC31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura. Histopathology. 2001;38:528–34.
Di Loreto C, Pubglisi F, Di Lauro V, et al. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Cancer Lett. 1998;13:73–8.
Bakir K, Kocer NE, Deniz H, et al. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of adenocarcinoma and pleural mesothelioma. Ann Diagn Pathol. 2004;8:337–41.
Khoor A, Whitset JA, Stahlman MT, et al. Utility of surfactant protein B precursor and thyroid transcription factor-1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol. 1999;30:695–700.
Skov BG, Lauritzen AF, Hirsch FR, et al. Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology. 1993;25:431–7.
Moch H, Oberholzer M, Christen H, et al. Diagnostic tools for differentiating pleural mesothelioma from lung adenocarcinoma in paraffin embedded tissue. Part II. Virchows Arch A. 1993;423:493–6.
Brown RW, Clark GM, Tandon AK, et al. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol. 1993;24:347–54.
Jordon D, Jagirdar J, Kaneko M. Blood group antigens, Lewis and Lewis, in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma. Am J Pathol. 1989;135:931–7.
Ordonez NG. Mesotheliomas with crystalloid structures: report of nine cases, including one with oncocytic features. Mod Pathol. 2012;25:272–81.
Carter D, Otis CN. Three types of spindle cell tumors of the pleura. Fibroma, sarcoma, and sarcomatoid mesothelioma. Am J Surg Pathol. 1988;12:747–53.
Kannerstein M, Churg J. Desmoplastic diffuse malignant mesothelioma. In: Fenoglio CM, Wolff M, editors. Progress in surgical pathology, vol. 11. New York: Masson Publishing; 1980. p. 19–29.
Cantin R, al-Jabi M, McCaughey WTE. Desmoplastic diffuse mesothelioma. Am J Surg Pathol. 1982;6:215–22.
Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy. Am J Clin Pathol. 1998;110:191–9.
Colby TV. The diagnosis of desmoplastic malignant mesothelioma. Am J Clin Pathol. 1998;110:135–6.
Henderson DW. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol. 1988;12:367–84.
Rice D. Surgery for malignant pleural mesothelioma. Ann Diagn Pathol. 2009;13(1):65–72.
Harwood TR, Gracey DR, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol. 1976;65:159–67.
Koss MN, Travis W, Moran C, Hochholzer L. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol. 1992;9:117–23.
Nishimoto Y, Ohno T, Saito K. Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study. Acta Pathol Jpn. 1983;33:415–23.
Dessy E, Pietra G. Pseudomesotheliomatous carcinoma of the lung: an immunohistochemical and ultrastructural study of three cases. Cancer. 1991;68:1747–53.
Shah I, Salvatore JR, Kummet T, et al. Pseudomesotheliomatous carcinoma involving pleura and peritoneum: a clinicopathological and immunohistochemical study of three cases. Ann Diagn Pathol. 1999;3:148–59.
Attanos RL, Gibbs AR. Pseudomesotheliomatous carcinomas of the pleura: a 10-year analysis of cases from the environmental lung disease research group, Cardiff. Histopathology. 2003;43:444–52.
Koss MN, Fleming M, Pzygodski RM, et al. Adenocarcinoma simulating mesothelioma: a clinicopathological and immunohistochemical study of 29 cases. Ann Diagn Pathol. 1999;3:148–59.
Pardo J, Torres W, Martinez-Penuela A, et al. Pseudomesotheliomatous carcinoma of the lung with distinct morphology, immunohistochemistry, and comparative genomic hybridization profile. Ann Diagn Pathol. 2007;11:241–51.
Moran CA, Suster S. Primary mucoepidermoid carcinoma of the pleura: a clinicopathological study of two cases. Am J Surg Pathol. 2003;120:381–5.
Asa SL, Dardick I, Van Nostrand PAW, et al. Primary thyroid thymoma: a distinct clinicopathologic entity. Hum Pathol. 1988;19:1463–6.
Martin JME, Randhawa G, Temple WJ. Cervical thymoma. Arch Pathol Lab Med. 1986;110:354–7.
Yamashita H, Murakami N, Noguchi S, et al. Cervical thymoma. Acta Pathol Jpn. 1983;33:189–94.
Wadon A. Thymoma intratracheal. Am J Pathol. 1934;60:308–12.
Moran CA, Suster S, Fishback NF, Koss MN. Intrapulmonary thymoma: a clinicopathologic correlation of eight cases. Am J Surg Pathol. 1995;19:304–12.
Payne CB, Mornigstar WA, Chester EH. Thymoma of the pleura masquerading as diffuse mesothelioma. Am Rev Respir Dis. 1960;94:441–6.
Honma K, Shimada K. Metastasizing ectopic thymoma arising in the right thoracic cavity and mimicking diffuse pleural mesothelioma. An autopsy study of a case with review of the literature. Wien Klin Wochenschr. 1986;98:14–20.
Moran CA, Travis WD, de-Christenson M, Koss MN, Rosai J. Thymomas presenting as pleural tumors: report of eight cases. Am J Surg Pathol. 1992;16:138–44.
Vural M, Abali H, Oksuzog B, Akbulut M. An atypical presentation of thymoma with diffuse pleural dissemination mimicking mesothelioma. Cancer Invest. 2006;24:615–20.
Qing G, Ionescu DN, Colby TV, Leslie KO. A 75-year-old man with an asymptomatic pleural-based mass discovered on routine chest radiographs. Primary pleural thymoma. Arch Pathol Lab Med. 2006;130:e62–5.
Kim HS, Lee HJ, Cho SY, et al. Myasthenia gravis in ectopic thymoma presenting as pleural masses. Lung Cancer. 2007;57:115–57.
Yamazaki K, Yoshino I, Oba T, et al. Ectopic pleural thymoma presenting as a giant mass in the thoracic cavity. Ann Thorac Surg. 2007;83:315–7.
Shin DF, Wang JS, Tseng HH, Tiao VM. Primary pleural thymoma. Arch Pathol Lab Med. 1997;1221:79–82.
Higasiyama M, Doi O, Kodama K, et al. Ectopic primary thymoma: report of a case. Surg Today. 1996;26:747–50.
Fushimi H, Tanio Y, Koth K. Ectopic thymoma mimicking diffuse pleural mesothelioma: a case report. Hum Pathol. 1998;29:409–10.
Plaza JA, Dominguez F, Suster S. Cystic adenomatoid tumor of the mediastinum. Am J Surg Pathol. 2004;28:132–8.
Ikuta N, Tano M, Iwata M, et al. A case of adenomatoid mesothelioma of the pleura. Jpn J Thorac Dis. 1989;27:1540–4.
Kaplan MA, Tazelaar HD, Hayashi T, et al. Adenomatoid tumors of the pleura. Am J Surg Pathol. 1996;20:1219–23.
Flieder D, Moran CA, Travis WD, et al. Pleuro-pulmonary endometriosis and pulmonary ectopic deciduosis: a clinicopathologic and immunohistochemical study of 10 cases with emphasis in diagnostic pitfalls. Hum Pathol. 1998;12:1495–503.
Karpel JP, Appel D, Merav A. Pulmonary endometriosis. Lung. 1985;163:151–9.
Lattes R, Shepard F, Tovell H, et al. A clinical and pathological study of endometriosis of the lung. Surg Gynecol Obstet. 1956;103:552–8.
Foster DC, Stern JL, Buscema J, et al. Pleural and parenchyma pulmonary endometriosis. Obstet Gynecol. 1981;58:552–6.
Austin MB, Frierson HF, Fechner RE, et al. Endometrioma of the lung presenting as hemoptysis and a large pulmonary mass. Surg Pathol. 1988;1:165–9.
Witkin GB, Rosai J. Solitary fibrous tumor of the mediastinum. Report of 14 cases. Am J Surg Pathol. 1989;13:547–57.
Goodlad JR, Fletcher CDM. Solitary fibrous tumor arising at unusual sites: analysis of a series. Histopathology. 1991;19:512–22.
Dorfman DM, To K, Dickersin GR, et al. Solitary fibrous tumor of the orbit. Am J Surg Pathol. 1994;18:281–7.
Suster S, Nascimiento AG, Miettinen M, et al. Solitary fibrous tumor of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol. 1995;19:1257–66.
Scharifker D, Kaneko M. Localized fibrous “mesothelioma” of pleura (submesothelial fibroma): a clinicopathologic study of 18 cases. Cancer. 1979;43:627–35.
Dalton WT, Zolliker AS, McCaughey WTE, et al. Localized primary tumors of the pleura. An analysis of 40 cases. Cancer. 1979;44:1465–75.
Briselli M, Mark EJ, Dickersin R. Solitary fibrous tumor of the pleura. Eight new cases and review of 360 cases in the literature. Cancer. 1981;47:2678–89.
England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura: a clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.
Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor: consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol. 1994;18:992–8.
Chilosi M, Facchetti F, Dei Tos AP, et al. bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol. 1997;181:362–7.
Said JW, Nash G, Banks-Schlegel S, et al. Localized fibrous mesothelioma: an immunohistochemical and electron microscopic study. Hum Pathol. 1984;15:440–3.
Moran CA, Suster S, Koss MN. The spectrum of histopathologic growth patterns in benign and malignant fibrous tumors of the pleura. Semin Diagn Pathol. 1992;9:169–80.
McDougall A, McGarrity G. Extra-abdominal desmoid tumors. J Bone Joint Surg Br. 1979;61:373–7.
Brodsky JT, Gordon MS, Hajdu SI, et al. Desmoid tumors of the chest wall: a locally recurrent problem. J Thorac Cardiovasc Surg. 1992;104:900–3.
Varghese TK, Gupta R, Yeldandi AV, et al. Desmoid tumor of the chest wall with pleural involvement. Ann Thorac Surg. 2003;76:937–9.
Andino L, Cagle PT, Murer B, et al. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of B-catenin and cyclin D1 expression. Arch Pathol Lab Med. 2006;130:1503–9.
Wilson RW, Gallateau-Salle F, Moran CA. Desmoid tumors of the pleura: a clinicopathologic mimic of localized fibrous tumor. Mod Pathol. 1999;12:9–14.
Fetsch JF, Montgomery EA, Meis JM. Calcifying fibrous pseudotumor. Am J Surg Pathol. 1993;17:502–8.
Van Dorpe J, Ectors N, Geboes K, et al. Is calcifying fibrous tumor pseudotumor a late sclerosing stage of inflammatory myofibroblastic tumor? Am J Surg Pathol. 1999;23:329–35.
Nascimiento AF, Ruiz R, Hornick JL, et al. Calcifying fibrous “pseudotumor” clinicopathologic study of 15 cases and analysis of its relationship to inflammatory myofibroblastic tumor. Int J Surg Pathol. 2002;10:189–96.
Reed MK, Margraf LR, Nikaidoh H, et al. Calcifying fibrous pseudotumor of the chest wall. Ann Thorac Surg. 1996;62:873–4.
Maeda T, Hirose T, Furuya K, Kameoka K. Calcifying fibrous pseudotumor: an ultrastructural study. Ultrastruct Pathol. 1999;23:189–92.
Soyer T, Ciftci AO, Gucer S, et al. Calcifying fibrous pseudotumor of the lung: a previously unreported entity. J Pediatr Surg. 2004;39:1729–30.
Pinkard NB, Wilson RW, Lawless N, et al. Calcifying fibrous pseudotumor of the pleura: a report of three cases of a newly described entity involving the pleura. Am J Clin Pathol. 1996;105:189–94.
Hainaut P, Lesage V, Weynand B, et al. Calcifying fibrous pseudotumor (CFPT): a patient presenting with multiple pleural lesions. Acta Clin Belg. 1999;54:162–4.
Mito K, Kashima K, Daa T, et al. Multiple calcifying fibrous tumor of the pleura. Virchows Arch. 2005;446:78–81.
Ammar A, El Hammami S, Horchani H, et al. Calcifying fibrous pseudotumor of the pleura: a rare location. Ann Thorac Surg. 2003;76:2081–2.
Jang KS, Oh YH, Han HX, et al. Calcifying fibrous pseudotumor of the pleura. Ann Thorac Surg. 2004;78:87–8.
Kawahara K, Yasukawa M, Nakagawa K, et al. Multiple calcifying fibrous tumor of the pleura. Virchows Arch. 2005;447:1007–8.
Shibata K, Yuki D, Sakata K. Multiple calcifying fibrous pseudotumors disseminated in the pleura. Ann Thorac Surg. 2008;85:3–5.
Suh JH, Shin OR, Kim YH. Multiple calcifying fibrous pseudotumor of the pleura. J Thorac Oncol. 2008;3:1356–8.
Erasmus JJ, McAdams P, Patz EF, et al. Calcifying fibrous pseudotumor of pleura: radiologic features in three cases. J Comput Assist tomogr. 1996;20:763–5.
Zamecnik M, Michal M, Boudova L, Sulc M. CD34 expression in calcifying fibrous pseudotumours. Histopathology. 2000;36:182–91.
Adams AL, Castro CY, Singh P, Moran CA. Primary amyloidosis of the pleura mimicking mesothelioma. Ann Diagn Pathol. 2001;5:229–32.
Moran CA, Suster S, Koss MN. Smooth muscle tumours presenting as pleural neoplasms. Histopathology. 1995;27:227–34.
Gaertner E, Zeren EH, Fleming MV, et al. Biphasic synovial sarcomas arising in the pleural cavity. A clinicopathologic study of five cases. Am J Surg Pathol. 1996;20:36–45.
Angerval L, Enzinger FM. Extra skeletal neoplasms resembling Ewing’s sarcoma. Cancer. 1977;101:446–9.
Askin FB, Rosai J, Sibley R, Dehner LP, et al. Malignant small cell tumors of the thoracopulmonary region in children. Cancer. 1979;43:2438–51.
Gould V, Jannson D, Warren W. Primitive neuroectodermal tumors (PNET) of the chest wall in adults. Mod Pathol. 1991;4:115A (Abstract 681).
Hashimoto H, Enjoji M, Nakajima T, et al. Malignant neuroepithelioma (peripheral neuroblastoma). Am J Surg Pathol. 1983;7:309–18.
Lane S, Ironside JW. Extraskeletal Ewing’s sarcoma of the nasal fossa. J Laryngol Otol. 1990;104:570–3.
Soule EH, Newton W, Moon TE, et al. Extraskeletal Ewing’s sarcoma. A preliminary review of 26 cases encountered in the intergroup rhabdomyosarcoma study. Cancer. 1978;42:259–64.
Suster S, Ronnen M, Huczar M. Extraskeletal Ewing’s sarcoma of the scalp. Pediatr Dermatol. 1988;5:126–8.
Tefft M, Vawter GF, Metus A. Paravertebral “round cell” tumors in children. Radiology. 1969;92:1501–9.
Wigger JH, Salazar G, Blanc WA. Extraskeletal Ewing’s sarcoma. Arch Pathol Lab Med. 1977;101:446–9.
Fujii Y, Hongo T, Nakagawa Y, et al. Cell culture of small round cell tumor originating in the thoracopulmonary region, evidence for derivation from a primitive pluripotent cell. Cancer. 1989;64:43–51.
Yunis EJ, Agostini RM, Walpusk JA, et al. Glycogen in neuroblastomas. Am J Surg Pathol. 1979;3:199–208.
Guillespie JJ, Roth LM, Wills ER, et al. Extraskeletal Ewing’s sarcoma. Am J Surg Pathol. 1979;3:99–108.
Schmidt D, Mackay B, Ayala A. Ewing’s sarcoma with neuroblastoma like features. Ultrastruct Pathol. 1982;3:99–108.
Tsuji S, Hisaoka M, Morimitsu Y, et al. Peripheral primitive neuroectodermal tumour of the lung: report of two cases. Histopathology. 1998;33:369–74.
Kahn AG, Avagnina A, Nazar J, et al. Primitive neuroectodermal tumor of the lung. Arch Pathol Lab Med. 2001;125:397–9.
Mikami Y, Nakajima M, Hashimoto H, et al. Primary pulmonary primitive neuroectodermal tumor (PNET): a case report. Pathol Res Pract. 2001;197:113–9.
Imamura F, Funakoshi T, Nakamura S, et al. Primary primitive neuroectodermal tumor of the lung. Report of two cases. Lung Cancer. 2000;27:55–60.
Linnoila RI, Tsokos M, Triche TJ, et al. Evidence for neural origin and PAS-positive variants of the malignant small cell tumor of thoracopulmonary region (“Askin’s tumor”). Am J Surg Pathol. 1986;10:124–33.
Tsokos M, Linnoila RI, Chandra RS, et al. Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round cell tumors in children. Hum Pathol. 1984;15:575–84.
Gonzales-Crussi F, Wolfson SL, Misugi K, et al. Peripheral neuroectodermal tumors of the chest wall in childhood. Cancer. 1984;54:2519–27.
Ordonez NG. Application of immunohistochemistry in the diagnosis of soft tissue sarcomas: a review and update. Adv Anat Pathol. 1998;5(2):67–85.
Hill DA, Pfeifer JD, Marley EF, et al. WT1 staining reliability differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor: an immunohistochemical and molecular diagnostic study. Am J Clin Pathol. 2000;114:345–53.
Miettinen M, Chatten J, Paetau A, Stevenson A. Monoclonal antibody NB84 in the differential diagnosis of neuroblastoma and other small round cell tumors. Am J Surg Pathol. 1998;22:327–32.
Batsakis JG, El-Nagar A. Ewing’s sarcoma and primitive neuroectodermal tumors: cytogenetic cynosures seeking a common histogenesis. Adv Anat Pathol. 1997;4(4):207–20.
Brown NP, Reid MM, Malcolm AJ, et al. Cytogenetic abnormalities of small round cell tumours. Med Pediatr Oncol. 1994;23:124–9.
Peng JW, Triche TJ, Knutsen T, et al. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet. 1986;21:185–208.
Contesso G, Llombart-Bosch A, Terrier P, et al. Does malignant small round cell tumor of the thoracopulmonary region (Askin tumor) constitute a clinicopathologic entity? An analysis of 30 cases with immunohistochemical and electron-microcopy support treated at the Institute Gustave Roussy. Cancer. 1992;69:1012–20.
Falconieri G, Bussani R, Mirra M, Zanella M. Pseudomesotheliomatous angiosarcoma: a pleuropulmonary lesion simulating malignant pleural mesothelioma. Histopathology. 1997;30:419–24.
Chen L, Shih HJ, Seguerra E, Lin JH. Pathologic quiz case: a 39-year-old man with diffuse pleural thickening and massive hemothorax. Arch Pathol Lab Med. 2004;128:1299–300.
Pramesh CS, Madur BP, Raina S, et al. Angiosarcoma of the pleura. Ann Thorac Cardiovasc Surg. 2004;10:187–90.
Maglaras GC, Katsenos S, Kakadelis J, et al. Primary angiosarcoma of the lung and pleura. Monaldi Arch Chest Dis. 2004;61:234–6.
Liu SF, Hsieh MJ. Massive hemoptysis and hemothorax caused by pleuropulmonary angiosarcoma. Am J Emerg Med. 2002;20:374–5.
Alexiou C, Clelland CA, Robinson D, Morgan WE. Primary angiosarcomas of the chest wall and pleura. Eur J Cardiothorac Surg. 1998;14:523–6.
Roh MS, Seo JY, Hong SH. Epithelioid angiosarcoma of the pleura: a case report. J Korean Med Sci. 2001;16:792–5.
Kimura M, Ito H, Furuta T, et al. Pyothorax-associated angiosarcoma of the pleura with metastasis to the brain. Pathol Int. 2003;53:547–51.
Aozasa K, Naka N, Tomita Y, et al. Angiosarcoma developing from chronic pyothorax. Mod Pathol. 1994;7:906–11.
Del Frate C, Mortele K, Zanardi R, et al. Pseudomesotheliomatous angiosarcoma of the chest wall and pleura. J Thorac Imaging. 2003;18:200–3.
Zhang PJ, Livolvsi VA, Brooks JJ. Malignant epithelioid vascular tumors of the pleura: report of a series and literature review. Hum Pathol. 2000;31:29–34.
Crotty EJ, McAdams HP, Erasmus JJ, et al. Epithelioid hemangioendothelioma of the pleura: clinical and radiological features. AJR Am J Roentgenol. 2000;175:1545–9.
Bevelaqua FA, Valensi Q, Hulnick D. Epithelioid hemangioendothelioma: a rare tumor with variable prognosis presenting as a pleural effusion. Chest. 1988;93:665–6.
Attanos RL, Suvarna SK, Rhead E, et al. Malignant tumours of the pleura in “asbestos” workers and endothelial differentiation in malignant mesothelioma. Thorax. 2000;55:860–3.
Pinet C, Magnan A, Garbe L, et al. Aggressive form of pleural epithelioid hemangioendothelioma: complete response after chemotherapy. Eur Respir J. 1999;14:237–8.
Al-Shraim M, Mahboub B, Nelligan PC, et al. Primary pleural epithelioid hemangioendothelioma with metastases to the skin. A case report and literature review. J Clin Pathol. 2005;58:107–9.
Lin BTY, Colby T, Gown AM, et al. Malignant vascular tumors of the serous membranes mimicking mesothelioma: a report of 14 cases. Am J Surg Pathol. 1996;20:1431–9.
Saqi A, Nisbet L, Gagneja P, Leslie KO. Primary pleural epithelioid hemangioendothelioma with rhabdoid phenotype: report and review of the literature. Diagn Cytopathol. 2007;35:203–8.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weissferdt, A., Moran, C.A. (2013). Tumors of the Pleura. In: Diagnostic Pathology of Pleuropulmonary Neoplasia. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0787-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0787-5_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0786-8
Online ISBN: 978-1-4419-0787-5
eBook Packages: MedicineMedicine (R0)